Gordon research conference programs  by unknown
Cordon research conference programs 
Immunochemistry and immunobiology 
February 4-9,1996 
Holiday Inn, Ventura, CA, USA 
Lymphocyte development: part I 
Diane Mathis, INSERM/Strasbourg, France: Positive 
selection of CD4+ T cells 
Bernard Malissen, INSERM/Marseille-Luminy, France: 
Control of pre-T cell development 
David Schatz, HHMI/Yale University, USA: 
Differentiation of u(3 versus $5 T cells 
Lymphocyte development: part II 
Frederick Alt, HHMI/Children’s Hospital, USA: 
Mutational analysis ofT cell development 
Katia Georgopoulos, Massachusetts General Hospital, 
USA: Duelling fingers in Ikaros proteins 
Margorie Oettinger, Massachusetts General Hospital, 
USA: Biochemistry ON-D-J recombination 
Cell death in the immune system 
Shigekazu Nagata, Osaka University Medical School, 
Japan: Fas-mediated cell death mechanisms 
Tak Mak, Ontario Cancer Institute, Canada: 
Thymocyte negative selection 
Craig Thompson, HHMI/University of Chicago, USA: 
Differential roles of lymphokine and Bcl-2 related 
genes in controlling lymphocyte survival 
Yuri Lazebnik, Cold Spring Harbor Laboratories, USA: 
Molecular mechanisms of cell execution 
Nonconventional recognition by T cells 
Kirsten Fischer-Lindahl, HHMI/University of Texas 
Southwestern Medical Center, USA: Title TBA 
Michael Brenner, Harvard Medical School, USA: 
Non-protein antigen presentation to T cells by 
CD1 molecules 
HR MacDonald, Ludwig Institute of Cancer Research, 
Switzerland: Development and Function of NKl+ 
T cells 
Recognition by natural killer cells 
Eric 0 Long, NIAID/NIH, USA: Diversity and 
specificity of killer cell inhibitory receptors 
William Seaman, VAMC/UCSF, USA: Pathways of 
inhibition through NK lectin-like receptors 
Lewis Lanier, DNAX Research Institute, USA: 
Inhibitory MHC receptors on human NK and 
T lymphocytes 
David Raulet, University of California, Berkeley, USA: 
Development and function of MHC-specific 
NK subsets 
Co-stimulation of lymphocytes 
Jeffrey Bluestone, University of Chicago, USA: 
CD2WB7 Interactions regulate the development 
and progression of autoimmune disease 
Arlene Sharpe, Brigham and Women’s Hospital, USA: 
Dissecting the in uiuo function of the CD28/B7 
co-stimulatory pathway using B7-deficient mice 
Garnett Kelsoe, University of Maryland, USA: Role 
of co-stimulation in the development of Ig 
hypermutation and T cell memory 
Antigen presentation to T cells 
Antonio Lanzavecchia, Institut fur Immunologie, 
Switzerland: title TBA 
Per Peterson, RW Johnson Pharmaceutical Research 
Institute, USA: Class I antigen processing and 
presentation 
Dennis Zaller, Merck Research Laboratories, USA: Role 
of HLA-DM in antigen processing 
Ronald Germain, NIAID/NIH, USA: Consequences 
of T cell receptor engagement by variant MHC- 
peptide ligands 
AIDS 
Andrew McMichael, John Radcliffe Hospital, UK: 
Subversion of the anti-HIV immune response 
Didier Trono, The Salk Institute, USA: Intracellular 
trafficking in HIV infection 
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George Shaw, University of Alabama, USA: Viral 
dynamics in HIV-l infection 
Signal transduction/transcriptional regulation 
Gerald Crabtree, HHMI/Stanford University, USA: title 
TBA 
Victor Tybulewicz, National Institute of Medical 
Research, UK: The role of vav and syk in lympho- 
cyte: development and function 
Dan Littman, HHMI/UCSE USA: Tyrosine kinases and 
lineage specification in thymocyte development 
Roger Perlmutter, HHMI/University of Washington, 
USA: Distinct signals govern positive and 
negative selection 
Applications may be found in the October 13 issue of 
Science. 
Conference chair: 
David H Raulet, 
MCB - LSA 489 
University of California, Berkeley 
Berkeley, CA 94720, USA 
Oxygen radicals in biology 
February 11-l 6,1996 
Doubletree Hotel 
Ventura, CA, USA 
Oxygen radicals and air pollution 
Carroll E Cross, University of California at Davis, USA: 
Introduction to oxygen radicals & air pollution. 
Henry Jay Forman, University of Southern California, 
USA: NO, - Signaling by an environmental hazard 
Donald J Massaro, Georgetown University School of 
Medicine, USA: Environmental oxidants and lung 
cells - the oxygen toxicity model 
Kenneth B Adler, North Carolina State University, USA: 
Ozone - signal transduction and molecular 
responses 
Health benefits of plant-derived antioxidants 
Peter M Bran&y, University of London, England Genetic 
manipulation of the carotenoid synthetic pathway 
Wolfgang Schuch, Zeneca Plant Science, England: 
Genetic modification of tomatoes 
Wolf Bors, Institut Strahlenbiologie, Germany: 
Flavonoids: prooxidants or antioxidants? 
David Leake, University of Reading, England: 
Interactions of flavonoids with oxidized LDL: 
implications for atherosclerosis in vivo 
Debates 
1) Do carotenoids act as antioxidants in vivo? 
2) Are the flavonoid constituents of foods relevant 
antioxidants in vivo? 
Discussants include: Lester Packer, University of 
California, Berkeley, USA and Norman Krinsky, Tufts 
University Medical School, USA 
Oxygen radicals & aging 
Raj S Sohal, Southern Methodist University, USA: Is 
oxidative stress a causal factor in the aging 
process? 
Lora E Rikans, University of Oklahoma, USA: Lipid 
peroxidation, antioxidant protection, and aging 
Vincent J Cristofalo, Medical College of Pennsylvania, and 
Hahnemann University, USA: Alterations in gene 
expression resulting from oxidative stress and aging 
Caleb Finch, University of Southern California, USA: 
Free radicals, oxidative stress, brain aging, and 
Alzheimer’s disease 
Charles Epstein, University of California, San Francisco, 
USA: The effects of altered SOD activity in aging 
Rick Weindruch, University ofWisconsin, USA: Caloric 
intake, free radicals and mitochondrial aging 
Oxygen radicals, inflammation and 
rschemia/reperfusion injuries 
David Wink, DCT/NCI/NIH, USA: Oxidant-induced 
cytotoxicity: modulation by reactive metabolites 
of oxygen and nitrogen 
Tony Manning, Upjohn Laboratories, USA: Role 
of oxidants in the NF-KB mediated regulation of 
infhunmation 
Paul Kubes, University of Calgary, Canada: A balance 
between nitric oxide and oxidants regulates 
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leukocyte-endothelial cell interactions in 
inflammation 
Alex Sevanian, University of Southern California, USA: 
Derangement of phospholipid remodeling and 
repair pathways by ischemia and reperfusion 
Sharon Wahl, NIDR/NIH, USA: Free radicals and 
inflammatory joint disease 
Harry Nick, University of Florida, USA: Molecular 
regulation of MnSOD by inflammatory cytokines 
and LPS 
Oxygen radicals, growth arrest, apoptosis 
and cancer 
Enrique Cadenas, University of Southern California, 
USA: Reactive oxygen species generated by anti- 
cancer quinones induce p21 in tumor cells 
Catherine Pasquier, INSERM/Paris, France: Role of 
oxygen radicals in polymorphonuclear cell 
apoptosis 
Angelo Azzi, University of Bern, Switzerland: Control 
of cell proliferation by a-tocopherol 
Dana R Crawford, Albany Medical College, USA: 
Transient growth arrest during adaptation to 
oxidative stress 
Sten Orrenius, The Karolinska Institute, Sweden: Redox 
regulation of apoptotic cell death 
Applications may be found in the October 13 issue of 
Science or requested from the conference chair: 
Kelvin JA Davies 
Department of Biochemistry 
and Molecular Biology, 
The Albany Medical College 
Albany, NY 12208, USA 
Tel: 518 262 5364 Fax: 518 262 5689 
Chemistry and biology of peptides 
February 18-23,1996 
Doubletree Hotel 
Ventura, CA, USA 
Chemical/biological interfaces 
Peter G Schultz, University of California, Berkeley, USA: 
Lessons from the immune system: from catalysis 
to material science 
Steven K Burley, Rockefeller University, USA: 
Structure/function studies of the obesity 
hormone leptin 
Novel synthetic approaches 
Daniel H Rich, University of Wisconsin, USA: 
Peptidomimetics derived from natural products: 
synthesis and properties 
Barbara Imperiali, California Institute of Technology 
USA: Causes and consequences of asparagine- 
linked glycosylation 
K Barry Sharpless, Scripps Research Institute, USA: 
Asymmetric synthesis of amino acids 
Murray Goodman, University of California, San 
Diego, USA: Enantioselective peptidomimetics: 
lanthionine building blocks in drug design 
Receptor-ligand interactions 
Terry D Reisine, University of Pennsylvania, USA: 
Structure/function analysis of peptide receptors 
Todd Somers, Genentech, Inc., USA: Minimal bioac- 
tive conformation of peptidic growth hormone 
secretagogues 
Peter W Schiller, Clinical Research Institute of Montreal, 
Canada: Opioid peptides and peptidomimetics as 
pharmacological tools and potential drugs 
Combinatorial drug discovery 
Jack Baldwin, Pharmacopeia, Inc., USA: From solid 
phase peptide synthesis to small molecule combi- 
natorial libraries 
Eric M Gordon, Affymax, USA: Combinatorial 
organic synthesis: applications to drug discovery 
Roger Tung,Vertex Pharmaceuticals, USA: Confluence 
of combinatorial and rational drug design 
Richard A Houghten, Houghten Pharmaceuticals, USA: 
The ‘libraries from libraries’ concept for genera- 
tion of soluble peptidomimetic and organic com- 
binatorial libraries 
Peptide templates 
At-no F Spatola, University of Louisville, USA: 
Chemistry and biology of cyclic peptides 
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Victor J Hruby, University ofArizona, USA: Exploring 
topographical space in de ~OVO design: prospects 
and problems 
M Reza Ghadiri, Scripps Research Institute, USA: 
Peptide nanotubes 
Peptide design 
Andrew Hamilton, University of Pittsburgh, USA: 
Design, synthesis and evaluation of pep- 
tidomimetic inhibitors of ras farnesyltransferase: a 
new class of anti-tumor agents 
J ean Chmielewski, Purdue University, USA: 
Dissociation of dimeric proteins: a novel means of 
enzyme inhibition 
Daniel F Veber, SmithKline Beecham Pharmaceuticals, 
USA: Studies of solid phase methodology for pep- 
tidomimetic libraries 
James A Wells, Genentech, Inc., USA: Shrinking pro- 
teins to peptides 
Peptides in immunobiology and inflammation 
Mark M Davis, Stanford University, USA: Biological 
and chemical aspects ofT-CelI recognition 
Hidde L Ploegh, Massachusetts Institute of Technology, 
USA: Creative use of peptides in immunology 
Douglas K Miller, Merck Research Laboratories, USA: 
Role of ICE family of cysteine proteases in IL-1 
activation and apoptosis 
Peptides as structural models 
Neville Kallenbach, NewYork University, USA: Peptide 
models for dissecting alpha-helical stability 
Clare Woodward, University of Minnesota, USA: NMR 
characterization of folding intermediates made by 
peptide synthesis 
Peter T Lansbury, Jr, Massachusetts Institute of 
Technology, USA: Amyloid formation in 
Alzheimer’s disease and scrapie 
Timothy A Keiderling, University of Illinois at Chicago, 
USA: Conformational studies of peptides using 
optical spectroscopy 
Applications may be found in the October 13 issue of 
Science or requested from the conference co-chairs: 
Charles M Deber 
Research Institute - Biochemistry 
Hospital for Sick Children/University ofToronto 
555 University Avenue 
Toronto, Ontario M5G 1X8, Canada 
Tel: 416 813 5924 Fax: 416 813 5005 
John A Smith, 
Department of Pathology 
The University of Alabama at Birmingham 
619 South 19th Street,WP P230 
Birmingham, AL 35233-7331, USA 
Tel: 205 934 6421 Fax: 205 975 4468 
